Sun Pharmaceutical Industries’ Appoints Kirti Ganorkar As MD; Dilip Shanghvi To Continue As Executive Chairman

The Board of Directors of Sun Pharmaceutical Industries Limited has approved Kirti Ganorkar’s appointment as Managing Director, effective 1 September 2025, for a term of five years, subject to the approval of the shareholders at the upcoming AGM. Further, the Board of Directors has noted the change in designation of Dilip Shanghvi as the Executive Chairman effective 1 September 2025.

Kirti Ganorkar has been heading India Business at Sun Pharma since June 2019. Previously, he has held various leadership roles across business development, marketing, M&A, new product introduction, project management, IP and litigation at Sun Pharma. He played a key role in driving Sun Pharma’s foray into specialty by securing rights for innovative products such as Ilumya. A chemical engineer and MBA, he joined Sun Pharma in 1996.

a

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: